Skip to main content
OpenTrials
Completed

NCT Number: NCT05985967

Therapeutic Modalities on Exercise Performance and Post-exercise Recovery of CrossFit® Athletes

Crossfit® is a training modality that consists in functional movements, constantly varied and executed at high intensity. Both training sessions and competitions involve physically demanding activities, which in addition to being performed at very high intensity also involves the aerobic metabolism pathway. These characteristics led to very high metabolic and muscular stress, as well as decrease in physical performance immediately after competitions and training sessions. The cumulative effects of the metabolic and muscular stress can be a precursor of injuries. Studies using different therapeutic modalities aiming to improve post-exercise recovery are needed in order to tackle this issue.

However, to the date there are no studies investigating the effects of different therapeutic modalities in an exercise modality such as Crossfit®. Therefore, the aim of this project is to assess the effects of different therapeutic modalities on performance and muscle recovery of Crossfit® athletes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–35 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Laboratory of Phototherapy and Innovative Technologies in Health

São Paulo, 01504-001, Brazil

About this study

It will be carried out a randomized, crossover, controlled trial.

Volunteers will be allocated to four interventions, and the order of the interventions will be randomized.

The outcomes will be obtained at baseline (prior to the Workout of the Day - WOD), and in different timepoints after that.

The WOD will be consisted in finishing as quickly as possible a sequence of three exercises (Calories in Assault AirBike®, Hang Squat Clean and Box Jump Over), in a well-known series model for the athletes, without rest.

The investigators will analyze: the maximum number of free squats performed in 1 minute; the activity of creatine kinase (CK); the levels of Interleukin-6 (IL-6); the ratings of perceived exertion; and the volunteers satisfaction with the interventions.

All data will be analyzed both in their absolute values and in relation to their percentage variation from the values obtained in the pre-WOD (baseline) assessments.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Crossfit® amateur male athletes
  • Do not present a history of musculoskeletal injury in the regions of the hips, knees and calves in the month preceding the study;
  • Are not using pharmacological agents;
  • Athletes should have been practicing the sport for at least 1 year;
  • Voluntarily commit to participate in all stages of the study.

Exclusion criteria

  • Present musculoskeletal or joint injuries during data collection.

Treatment and study plan

PBMT-sMF

Device

PBMT-sMF applied in the lower limbs with different doses per muscle group.

Shock wave

Device

Shock wave therapy applied in the lower limbs for 30 minutes.

Pneumatic compression

Device

Pneumatic compression applied in the lower limbs for 30 minutes.

Passive recovery

Other

Volunteers laid in supine position resting for 30 minutes.

Primary outcomes

  1. Change in functional capacity

    Time frame: 1hour, 24 hours and 48 hours after WOD (workout of the day).

    The functional capacity will be assessed through the maximum number of free squat repetitions performed within 1 minute.

Secondary outcomes

  1. Change in the activity of creatine kinase (CK)

    Time frame: 1 hour, 24 hours and 48 hours after WOD (workout of the day).

    The activity of CK will be analyzed from the blood samples collected from the participants through spectrophotometry and using specific reagent kits.

  2. Change in the levels of interleukin-6 (IL-6)

    Time frame: 1 hour, 24 hours and 48 hours after WOD (workout of the day).

    The levels of interleukin-6 will be analyzed from the blood samples collected from the participants through enzyme-linked immunosorbent assay (ELISA) and using specific reagent kits.

  3. Participants' perceived exercise intensity

    Time frame: 1 minute after WOD (workout of the day), 1 minute post-treatment/intervention, 1 hour, 24 hours and 48 hours after WOD.

    The perception of exercise intensity will be assessed through a 0-100 Ratings of Perceived Exertion Scale: in this scale lower score, means lower degree of fatigue and higher score, means higher degree of fatigue.

  4. Participants' satisfaction regarding the interventions

    Time frame: 48 hours after WOD (workout of the day).

    The participants satisfaction regarding the interventions will be assessed through the LIKERT scale

Sponsors and collaborators

Lead sponsor

University of Nove de Julho

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Aug 14, 2023
Registry last updated
Sep 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.